Metastatic Adenocarcinoma of the Pancreas Clinical Trial
Official title:
An Open Non-randomized Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Tarceva in Combination With Capecitabine in Patients With Advanced Pancreatic Cancer
The purpose of this study is to determine efficacy of the treatment with erlotinib in combination with capecitabine in patients with advanced pancreatic cancer.
This efficacy will be determined by objective response rate following RECIST criteria. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05557851 -
Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
|
Phase 1 | |
| Not yet recruiting |
NCT06225999 -
Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas
|
Phase 2 | |
| Terminated |
NCT01654861 -
Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)
|
Phase 1 | |
| Active, not recruiting |
NCT04083235 -
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
|
Phase 3 | |
| Completed |
NCT02184195 -
Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
|
Phase 3 | |
| Recruiting |
NCT02739633 -
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
|
Phase 2 |